ATRORIF-P

SMALL DOSE, BIG CONTROL ON CHILDHOOD MYOPIA

ATRORIF-P

Atropine Sulphate 0.01% w/v Eye Drops / 5ml

ADVANCED MYOPIA MANAGEMENT STRATEGY

• Progression Control is shown to have a considerable reduction on the progression of childhood myopia during school going ages.
• The Low-Dose Precision is a modulator of the muscarinic receptors to regulate the myopia without much impact on near-vision accommodation.
• Self-Preserved Technology utilizes an ionic buffered system to ensure a lower risk of ocular surface toxicity.
• Pediatric Safety ideal for long-term daily use in sensitive pediatric eyes.
• Relief in Progressive myopia (between 2.00d & 8.00d) and long-term myopia management in children.